| 标题 |
Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small cell lung cancer: 7-year update from the phase 3 CROWN study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:A.T. Shaw; B.J. Solomon; E. Felip; T.M. Bauer; G. Liu; et al 出版日期:2026-05-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)